Results 21 to 30 of about 383,894 (265)

Incidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012. [PDF]

PLoS ONE, 2015
Streptococcus pneumoniae is a leading cause of pneumonia worldwide. However, the burden of pneumococcal pneumonia among adults in low- and middle-income countries is not well described.Data from 2008-2012 was analyzed from two surveillance sites in ...
Carmen Lucía Contreras, Jennifer R Verani, María Renee Lopez, Antonio Paredes, Chris Bernart, Fabiola Moscoso, Aleida Roldan, Wences Arvelo, Kim A Lindblade, John P McCracken   +9 more
doaj   +1 more source

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study

PLoS Medicine, 2020
Background Vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is available in the United Kingdom to adults aged 65 years or older and those in defined clinical risk groups.
H. Lawrence, H. Pick, V. Baskaran, P. Daniel, C. Rodrigo, D. Ashton, Rochelle C Edwards-Pritchard, C. Sheppard, S. Eletu, D. Litt, N. Fry, Samuel Rose, C. Trotter, T. McKeever, W. Lim   +14 more
semanticscholar   +1 more source

PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)

Microorganisms, 2022
The Community-Acquired Pneumonia immunization Trial in Adults (CAPiTA) evaluated older adult pneumococcal vaccination and was one of the largest vaccine clinical trials ever conducted.
C. Theilacker, M. Fletcher, L. Jodar, B. Gessner   +3 more
semanticscholar   +1 more source

A Retrospective Analysis to Estimate the Burden of Invasive Pneumococcal Disease and Non-Invasive Pneumonia in Children <15 Years of Age in the Veneto Region, Italy

Children, 2022
Despite advances in preventative interventions, invasive pneumococcal disease and pneumonia cause significant morbidity and mortality in children. We studied the annual incidence of pneumococcal-specific and syndromic invasive disease and non-invasive ...
Elisa Barbieri, Gloria Porcu, Tianyan Hu, Tanaz Petigara, Francesca Senese, Gian Marco Prandi, Antonio Scamarcia, Luigi Cantarutti, Anna Cantarutti, Carlo Giaquinto   +9 more
doaj   +1 more source

Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.

Journal of Clinical Investigation, 2020
Patients with respiratory syncytial virus (RSV) infection exhibit enhanced susceptibility to subsequent pneumococcal infections. However, the underlying mechanisms involved in this increased susceptibility remain unclear.
T. Shibata, Airi Makino, Ruiko Ogata, Shigeki Nakamura, Toshihiro Ito, K. Nagata, Yoshihiko Terauchi, T. Oishi, M. Fujieda, Yoshimasa Takahashi, M. Ato   +10 more
semanticscholar   +1 more source

Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc Immunother 2020)

Human Vaccines & Immunotherapeutics, 2021
The recently published article by Shami et al. describes a cost-effectiveness analysis of sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23 ...
Ulrike K. Buchwald, Temitope Folaranmi, Thomas Weiss   +2 more
doaj   +1 more source

Pneumococcal carriage and serotype distribution among children with and without pneumonia in Mozambique, 2014-2016.

PLoS ONE, 2018
BackgroundPneumococcal colonization is a precursor to pneumonia, and pneumococcal conjugate vaccines (PCV) can decrease vaccine-type (VT) colonization.
Tolulope Adebanjo, Fernanda C Lessa, Helio Mucavele, Benild Moiane, Alberto Chauque, Fabiana Pimenta, Sergio Massora, Maria da Gloria Carvalho, Cynthia G Whitney, Betuel Sigauque   +9 more
doaj   +1 more source

Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays [PDF]

Clinical Infectious Diseases, 2017
Richard G. Wunderink, Wesley H. Self, Evan J. Anderson, R.A. Balk, Sherene Fakhran, D. Mark Courtney, Chao Qi, Derek J. Williams, Yuwei Zhu, Cynthia G. Whitney, Matthew R. Moore, Anna M. Bramley, Seema Jain, Kathryn M. Edwards, Carlos G. Grijalva   +14 more
openalex   +2 more sources

Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia.

PLoS ONE, 2014
BackgroundEven though the pathogenicity and invasiveness of pneumococcus largely depend on capsular types, the impact of serotypes on post-viral pneumococcal pneumonia is unknown.Methods and findingsThis study was performed to evaluate the impact of ...
Joon Young Song, Moon H Nahm, Hee Jin Cheong, Woo Joo Kim   +3 more
doaj   +1 more source

Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States

mBio, 2011
A seven-valent pneumococcal conjugate vaccine (PCV7) introduced in the United States in 2000 has been shown to reduce invasive pneumococcal disease (IPD) in both vaccinated children and adults through induction of herd immunity. We assessed the impact of
Lone Simonsen, Robert J. Taylor, Yinong Young-Xu, Michael Haber, Larissa May, Keith P. Klugman   +5 more
doaj   +1 more source